The authors determined that tumor-derived ANGPTL2 stimulates lung epithelial cells, which is essential for primary tumor-induced neutrophil recruitment in lung and subsequent pre-metastatic niche formation.
Researchers have carried out the first comprehensive survey of viruses found within different types of cancer. An international team systematically investigated the DNA found within more than 2,600 tumor samples from patients with 38 different types of cancer. They discovered traces of viruses in 13% of the samples studied, and also further identified some of the mechanisms that viruses use to trigger carcinogenic mutations.
A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a protein known as heat shock protein 47 could be key for suppressing breast cancer metastasis.
A new global study has found that the majority of women are unhappy with the size of their breasts -- a finding that has important public health implications.
Early signs of cancer can appear years before diagnosis and developing tests for these genetic signs could provide new ways to spot cancer early, according to new research led by the Crick and EMBL-EBI.
Surgeons at UT Southwestern have developed a process to determine the best approach for single breast reconstruction.
A new study led by Stony Brook University Cancer Center researchers to be published in Nature Communications suggests that the choice of anesthesia may change the metastatic process of breast cancer by affecting the cytokine and microenvironment.
A newly published study in the journal Cancer Research signals a potential treatment breakthrough for patients with triple negative breast cancer -- a form of the disease that disproportionately affects and also tends to develop more aggressively in black women. The findings may also reclassify triple negative breast cancer as a different form of the disease that can be treated by combining already existing therapies.
Bluestar Genomics published a new study demonstrating the efficacy of their 5-hydroxymethylcytosine (5hmC) signal detection technology for its use in breast, lung, pancreatic, and prostate cancer.
Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017. They found that among 1,503 diverse young breast cancer patients, less than half (46.2 percent) completed hereditary breast and ovarian cancer genetic testing. However, the percentage of women who completed genetic testing increased over time from 15.3 percent in 2007 to a peak of 72.8 percent in 2015.